Our structure

Our work is focused on five areas covering public affairs, regulatory affairs, influenza, access to vaccines, and research and development.

Executive board

Florence
Baron-Papillon
President (Sanofi)
Juan Carlos
Jaramillo
Vice-President (Valneva)
Deborah
Scarano
Treasurer (Pfizer)
Andreas
Potthoff
(Abbott)
Sharon
McHale
(CSL Seqirus)
Carles
Fabrega
(HIPRA)
Guillermo
De Juan Echávarri
(GSK)
Jurgen
Kwik
(Janssen/JnJ)
Nicoletta
Luppi
(MSD)
Kelly
Cappio
(Novavax)
Alexander
Meier
(Moderna)

Executive office

Sibilia
Quilici
Executive Director
Laurent
Louette
Director, Public Affairs & Country Liaison
Anna
Czwarno
Director, Regulatory and R&D
Charlotte
Vernhes
Director, Scientific and Medical Affairs
Anna
Vicere
Senior Manager, Access Policy & Public Affairs
Andreea
Iordache
Manager, Science & Regulatory Affairs
Polina
Zoteva
Communications Lead
Anne
Meynaerts
Administrative Assistant

Working Group Chairs